The US Food and Drug Administration (FDA) has approved Novo Nordisk's Levemir (insulin detemir [rDNA origin] injection) for a pregnancy Category B classification. The approval indicates that Levemir, when used in pregnant women with ...
Tags: FDA approval, lable update, Levemir, clinical study